Propranolol heart palpitations
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest propranolol effectively reduces heart palpitations and symptoms of various cardiac conditions, though it may cause side effects like nausea and mental concentration impairment, and abrupt withdrawal can lead to transient symptoms.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Propranolol for Heart Palpitations: Efficacy and Clinical Insights
Introduction to Propranolol and Heart Palpitations
Propranolol, a non-selective beta-blocker, is widely used in the management of various cardiac conditions, including heart palpitations. Heart palpitations, characterized by an irregular or rapid heartbeat, can be distressing and are often associated with conditions such as paroxysmal cardiac arrhythmias, hyperkinetic heart syndrome, and orthostatic tachycardia. This article synthesizes research findings on the effectiveness of propranolol in treating heart palpitations.
Propranolol in Paroxysmal Cardiac Arrhythmias
Efficacy in Reducing Arrhythmias
Long-term treatment with propranolol has shown significant efficacy in managing paroxysmal cardiac arrhythmias. In a study involving 20 patients, propranolol completely abolished attacks of supraventricular tachycardia in some patients and significantly reduced the frequency and duration of attacks in others. Additionally, patients with paroxysmal atrial flutter or fibrillation experienced a notable reduction in attack frequency, and those with ventricular ectopic beats reported relief from palpitations despite the persistence of ectopic beats.
Side Effects and Complications
While propranolol is generally well-tolerated, some patients may experience side effects such as nausea and mental concentration impairment, which can be managed by adjusting the dosage. However, more serious complications like thrombocytopenic purpura have been reported in rare cases.
Propranolol for Hyperkinetic Heart Syndrome
Hemodynamic Improvements
In patients with primary hyperkinetic heart syndrome (PHHS), propranolol has been effective in reducing symptoms such as rapid and forceful heart action and palpitations. A two-year follow-up study demonstrated significant improvements in hemodynamic functions, including reductions in systolic arterial pressure and heart rate. The reappearance of symptoms upon switching to a placebo underscores the drug's efficacy in managing PHHS.
Propranolol in Orthostatic Tachycardia
Symptom Alleviation
Propranolol has also been effective in treating orthostatic tachycardia associated with orthostatic hypotension. In a case study, a patient experienced marked alleviation of symptoms such as palpitations, lightheadedness, and chest pains after propranolol administration, highlighting its role in managing this condition.
Dose-Dependent Effects
Research on postural tachycardia syndrome (POTS) indicates that low-dose propranolol (20 mg) significantly reduces heart rate and improves symptoms more effectively than higher doses. This suggests that lower doses may be preferable for symptom management in POTS patients.
Propranolol Withdrawal Phenomena
Supersensitivity and Symptoms
Abrupt discontinuation of propranolol can lead to withdrawal phenomena, including transient supersensitivity to chronotropic effects and symptoms such as palpitations, headache, and chest pain. These effects typically begin a few days after withdrawal and can last for over a week, emphasizing the need for careful management when discontinuing the drug .
Conclusion
Propranolol is a potent beta-blocker that effectively manages heart palpitations across various conditions, including paroxysmal cardiac arrhythmias, hyperkinetic heart syndrome, and orthostatic tachycardia. While generally well-tolerated, it is important to monitor for side effects and manage withdrawal carefully. Lower doses may be more effective for certain conditions like POTS, providing significant symptom relief without the need for higher doses. Overall, propranolol remains a valuable option in the therapeutic arsenal for heart palpitations.
Sources and full results
Most relevant research papers on this topic
